NSCLC cells that express high levels of AXL generally expressed abundant vimentin, a transcriptional regulator that contributes to EMT phenotypes [87], and downregulation of AXL decreased expression of vimentin in NSCLC [74,87,112]. This evidence concerns the gene AXL and non-small cell lung carcinoma.